[Form 4] Life360, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Life360, Inc. (LIF) Chief Financial Officer updates holdings and corrects prior option terms. The reporting person exercised a stock option and acquired 6,500 shares of Life360 common stock on 11/19/2025 at an exercise price of $3.58 per share. After the transaction, the reporting person directly held 98,232 common shares and indirectly held 72,553 shares through the Russell John Burke Revocable Trust.

The filing notes that 9,523 directly held shares were previously transferred to the revocable trust under an exemption from Section 16. It also states that 91,732 restricted stock units are included in the beneficial ownership total, each representing a right to receive one common share upon vesting. The stock option underlying this exercise is now fully vested and exercisable, and the vesting terms previously reported for this option were inadvertently misreported and are corrected in this filing.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burke Russell John

(Last) (First) (Middle)

C/O LIFE360, INC.

1900 SOUTH NORFOLK STREET, SUITE 310

(Street)

SAN MATEO CA 94403

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Life360, Inc. [ LIF ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
11/19/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common stock	11/19/2025		M		6,500	A	$3.58	98,232(1)(2)	D
Common Stock								72,553(1)	I	Held by the Russell John Burke Revocable Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$3.58	11/19/2025		M			6,500	(3)	05/19/2030	Common stock	6,500	$0	434,014	D

Explanation of Responses:

1. The Reporting Person transferred 9,523 directly held shares to the Russell John Burke Revocable Trust, which transfer was exempt from Section 16 pursuant to Rule 16a-13 under the Securities Exchange Act of 1934, as amended.

2. Includes 91,732 restricted stock units previously granted, each of which represents a contingent right to receive one share of the Issuer's common stock upon vesting.

3. The stock option vested and became exercisable as to 50% of the total number of shares over a four-year period with a one-year cliff, such that 25% vested and became exercisable on May 11, 2021, and the remaining shares vested in 47 equal monthly installments thereafter; and as to 50% of the total number of shares over a three-year period with a one-year cliff, such that 25% vested and became exercisable on May 11, 2021, and the remaining shares vested in 35 equal monthly installments thereafter, subject to the continuing employment of the Reporting Person on each vesting date. The stock option is now fully vested and exercisable.

Remarks:

The vesting terms for the stock option reported herein were inadvertently misreported on the Reporting Person's initial Form 3 filed on June 27, 2022, and subsequent Forms 4 reporting transactions in the stock option, and have been corrected as of this Form 4.

	/s/ Allison Chang, Attorney-in-Fact	11/21/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Life360 (LIF) report in this Form 4?

The Chief Financial Officer exercised a stock option and acquired 6,500 shares of Life360 common stock on 11/19/2025 at an exercise price of $3.58 per share.

How many Life360 (LIF) shares does the reporting person own after this transaction?

Following the transaction, the reporting person beneficially owned 98,232 common shares directly and 72,553 common shares indirectly through the Russell John Burke Revocable Trust.

What is noted about restricted stock units for Life360 (LIF) in this filing?

The beneficial ownership figure includes 91,732 restricted stock units, each representing a contingent right to receive one share of Life360 common stock upon vesting.

What does the Form 4 say about prior reporting of the stock option vesting terms for Life360 (LIF)?

The filing states that the vesting terms for the reported stock option were inadvertently misreported on the initial Form 3 and subsequent Forms 4, and that these terms have now been corrected.

Was there any share transfer to a trust mentioned for Life360 (LIF)?

Yes. The filing explains that the reporting person transferred 9,523 directly held shares to the Russell John Burke Revocable Trust in a transaction exempt from Section 16 under Rule 16a-13.

Is the stock option in this Life360 (LIF) Form 4 now fully vested?

Yes. The filing states that the stock option reported is now fully vested and exercisable after vesting over multi-year schedules with one-year cliffs and monthly installments.